Business Daily from THE HINDU group of publications
Friday, Dec 01, 2006
ePaper
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

 Corporate - Regulatory Bodies & Rulings
USFDA inspects Divi's Labs unit

Our Bureau

Hyderabad , Nov. 30

Divi's Laboratories has said that its Unit-2, comprising both export-oriented units and special economic zone at Chippada villagenear Visakhapatnam have been inspected by the US Federal Drug Administration.

The purpose of the inspection was product pre-approval and general eGMP (Current Good Manufacturing Practices), a company press release said.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
6 feared dead in Eastern Coalfields mine

Korean co to discuss jt venture with FACT
PSL bags Rs 308-crore order
REL bags corporate governance award
Sarda bail plea rejected again
Court directive on Sujana
Nod for Indo Rama Petro merger plan
LN Mittal, Farallon Cap pick 13.33% in Indiabulls Infra
Bedlam in West Bengal Assembly
Bengal Govt bans protests at Singur
Buddhadeb assures full protection to Tatas
Arch Chem of US opens office in Mumbai
Financial Tech gets nod to set up Global Board of Trade
USFDA inspects Divi's Labs unit
Uttam Galva in pact with Sumitomo arm
GMR ties up with Accor Hotels
Companies take to e-filing returns in a big way
Eros Group to draw up Rs 5,000-cr fund
Balakrishnan front-runner for HPCL chief post

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line